{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:35:34Z","timestamp":1791599734556,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1038\/s41585-023-00830-2","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:01:49Z","timestamp":1701363709000},"page":"243-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-918X","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry N.","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0996-0350","authenticated-orcid":false,"given":"Jason","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-8601","authenticated-orcid":false,"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-246X","authenticated-orcid":false,"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossano","family":"Girometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-0599","authenticated-orcid":false,"given":"Valdair F.","family":"Muglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-5058","authenticated-orcid":false,"given":"Giacomo","family":"Novara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5242-7060","authenticated-orcid":false,"given":"Francesco","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-9025","authenticated-orcid":false,"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebert A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Barentsz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00181125","volume":"6","author":"JO Barentsz","year":"1996","unstructured":"Barentsz, J. O., Jager, G. J., Witjes, J. A. & Ruijs, J. H. J. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur. Radiol. 6, 129\u2013133 (1996).","journal-title":"Eur. Radiol."},{"key":"830_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1148\/radiology.207.3.9609906","volume":"207","author":"JO Barentsz","year":"1998","unstructured":"Barentsz, J. O. et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207, 791\u2013797 (1998).","journal-title":"Radiology"},{"key":"830_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1148\/radiology.201.1.8816542","volume":"201","author":"JO Barentsz","year":"1996","unstructured":"Barentsz, J. O. et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201, 185\u2013193 (1996).","journal-title":"Radiology"},{"key":"830_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2214\/ajr.160.5.8470608","volume":"160","author":"JO Barentsz","year":"1993","unstructured":"Barentsz, J. O., Ruijs, S. H. & Strijk, S. P. The role of MR imaging in carcinoma of the urinary bladder. Am. J. Roentgenol. 160, 937\u2013947 (1993).","journal-title":"Am. J. Roentgenol."},{"key":"830_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1148\/radiology.157.2.4048458","volume":"157","author":"MR Fisher","year":"1985","unstructured":"Fisher, M. R., Hricak, H. & Tanagho, E. A. Urinary bladder MR imaging. Part II. Neoplasm. Radiology 157, 471\u2013477 (1985).","journal-title":"Radiology"},{"key":"830_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/rg.322115125","volume":"32","author":"S Verma","year":"2012","unstructured":"Verma, S. et al. Urinary bladder cancer: role of MR imaging. RadioGraphics 32, 371\u2013387 (2012).","journal-title":"RadioGraphics"},{"key":"830_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco, V. et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur. Urol. 74, 294\u2013306 (2018).","journal-title":"Eur. Urol."},{"key":"830_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz, J. O. et al. ESUR prostate MR guidelines 2012. Eur. Radiol. 22, 746\u2013757 (2012).","journal-title":"Eur. Radiol."},{"key":"830_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb, J. C. et al. PI-RADS prostate imaging \u2014 reporting and data system: 2015, version 2. Eur. Urol. 69, 16\u201340 (2016).","journal-title":"Eur. Urol."},{"key":"830_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey, B. et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur. Urol. 76, 340\u2013351 (2019).","journal-title":"Eur. Urol."},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1007\/s00261-022-03669-0","volume":"47","author":"SB Jazayeri","year":"2022","unstructured":"Jazayeri, S. B. et al. Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis. Abdom. Radiol. 47, 4173\u20134185 (2022).","journal-title":"Abdom. Radiol."},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1007\/s00330-020-06802-z","volume":"30","author":"C Luo","year":"2020","unstructured":"Luo, C., Huang, B., Wu, Y., Chen, J. & Chen, L. Use of vesical imaging-reporting and data system (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. Eur. Radiol. 30, 4606\u20134614 (2020).","journal-title":"Eur. Radiol."},{"key":"830_CR13","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00345-022-03969-6","volume":"40","author":"F Del Giudice","year":"2022","unstructured":"Del Giudice, F. et al. The accuracy of vesical imaging-reporting and data system (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations. World J. Urol. 40, 1617\u20131628 (2022).","journal-title":"World J. Urol."},{"key":"830_CR14","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s00261-022-03449-w","volume":"47","author":"Y Feng","year":"2022","unstructured":"Feng, Y., Zhong, K., Chen, R. & Zhou, W. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis. Abdom. Radiol. 47, 1396\u20131405 (2022).","journal-title":"Abdom. Radiol."},{"key":"830_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urolonc.2021.11.008","volume":"40","author":"SB Jazayeri","year":"2022","unstructured":"Jazayeri, S. B. et al. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: a systematic review and diagnostic meta-analysis. Urol. Oncol. 40, 45\u201355 (2022).","journal-title":"Urol. Oncol."},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/cancers12102994","volume":"12","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice, F. et al. Systematic review and meta-analysis of vesical imaging-reporting and data system (VI-RADS) inter-observer reliability: an added value for muscle invasive bladder cancer detection. Cancers 12, 2994 (2020).","journal-title":"Cancers"},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo, S. et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur. Urol. Oncol. 3, 306\u2013315 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"830_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semradonc.2022.10.002","volume":"33","author":"E Messina","year":"2023","unstructured":"Messina, E. et al. Seeing is believing: state of the art imaging of bladder cancer. Semin. Radiat. Oncol. 33, 12\u201320 (2023).","journal-title":"Semin. Radiat. Oncol."},{"key":"830_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27361","volume":"55","author":"V Panebianco","year":"2022","unstructured":"Panebianco, V. et al. VI-RADS for bladder cancer: current applications and future developments. J. Magn. Reson. Imaging 55, 23\u201336 (2022).","journal-title":"J. Magn. Reson. Imaging"},{"key":"830_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","volume":"77","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice, F. et al. Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non\u2013muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur. Urol. 77, 101\u2013109 (2020).","journal-title":"Eur. Urol."},{"key":"830_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jmri.27807","volume":"55","author":"B Cao","year":"2022","unstructured":"Cao, B. et al. Preliminary exploration of the application of vesical imaging reporting and data system (VI\u2010RADS) in post\u2010treatment patients with bladder cancer: a prospective single\u2010center study. Magn. Reson. Imaging 55, 275\u2013286 (2022).","journal-title":"Magn. Reson. Imaging"},{"key":"830_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bju.15188","volume":"126","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice, F. et al. Preoperative detection of VI-RADS (Vesical Imaging-Reporting and Data System) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time-to-cystectomy: time to reconsider the nee. BJU Int. 126, 610\u2013619 (2020).","journal-title":"BJU Int."},{"key":"830_CR23","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1007\/s00330-023-09627-8","volume":"33","author":"K Kimura","year":"2023","unstructured":"Kimura, K. et al. Novel utility of vesical imaging-reporting and data system in multimodal treatment for muscle-invasive bladder cancer. Eur. Radiol. 33, 6245\u20136255 (2023).","journal-title":"Eur. Radiol."},{"key":"830_CR24","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1007\/s00261-022-03455-y","volume":"47","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging. Abdom. Radiol. 47, 2148\u20132157 (2022).","journal-title":"Abdom. Radiol."},{"key":"830_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","volume":"47","author":"M Pecoraro","year":"2022","unstructured":"Pecoraro, M. et al. Vesical imaging-reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom. Radiol. 47, 763\u2013770 (2022).","journal-title":"Abdom. Radiol."},{"key":"830_CR26","unstructured":"Witjes, A. et al. EAU guidelines on muscle-invasive and metastatic bladder cancer. uroweb https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer (2023)."},{"key":"830_CR27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","journal-title":"BMJ"},{"key":"830_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting, P. F. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155, 529 (2011).","journal-title":"Ann. Intern. Med."},{"key":"830_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eujim.2015.07.002","volume":"7","author":"EG Trevelyan","year":"2015","unstructured":"Trevelyan, E. G. & Robinson, P. N. Delphi methodology in health research: how to do it? Eur. J. Integr. Med. 7, 423\u2013428 (2015).","journal-title":"Eur. J. Integr. Med."},{"key":"830_CR30","first-page":"42","volume":"9","author":"JS Yeh","year":"2016","unstructured":"Yeh, J. S., Van Hoof, T. J. & Fischer, M. A. Key features of academic detailing: development of an expert consensus using the Delphi method. Am. Health Drug. Benefits 9, 42\u201350 (2016).","journal-title":"Am. Health Drug. Benefits"},{"key":"830_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 291, 668\u2013674 (2019).","journal-title":"Radiology"},{"key":"830_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00261-019-02190-1","volume":"45","author":"SH Kim","year":"2019","unstructured":"Kim, S. H. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor. Abdom. Radiol. 45, 491\u2013498 (2019).","journal-title":"Abdom. Radiol."},{"key":"830_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.21037\/tau.2020.02.16","volume":"9","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Evaluation of vesical imaging-reporting and data system (VI-RADS) scoring system in predicting muscle invasion of bladder cancer. Transl. Androl. Urol. 9, 445\u2013451 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"830_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00304-3","volume":"20","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer. Cancer Imaging 20, 26 (2020).","journal-title":"Cancer Imaging"},{"key":"830_CR35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jmri.27676","volume":"54","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Detecting muscle invasion of bladder cancer using a proposed magnetic resonance imaging strategy. J. Magn. Reson. Imaging 54, 1212\u20131221 (2021).","journal-title":"J. Magn. Reson. Imaging"},{"key":"830_CR36","first-page":"00136","volume":"S2588-9311","author":"Y Arita","year":"2022","unstructured":"Arita, Y. et al. Diagnostic value of the vesical imaging-reporting and data system in bladder urothelial carcinoma with variant histology. Eur. Urol. Oncol. S2588-9311, 00136\u20135 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"830_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19273-7","volume":"12","author":"TI Noh","year":"2022","unstructured":"Noh, T. I. et al. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS. Sci. Rep. 12, 20689 (2022).","journal-title":"Sci. Rep."},{"key":"830_CR38","doi-asserted-by":"publisher","first-page":"20190401","DOI":"10.1259\/bjr.20190401","volume":"92","author":"M Makboul","year":"2019","unstructured":"Makboul, M., Farghaly, S. & Abdelkawi, I. F. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Br J Radiol 92, 20190401 (2019).","journal-title":"Br J Radiol"},{"key":"830_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/JU.0000000000001373","volume":"205","author":"S Taguchi","year":"2021","unstructured":"Taguchi, S. et al. Prospective validation of vesical imaging-reporting and data system using a next-generation magnetic resonance imaging scanner-is denoising deep learning reconstruction useful? J. Urol. 205, 686\u2013692 (2021).","journal-title":"J. Urol."},{"key":"830_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clinimag.2021.02.026","volume":"77","author":"A Akcay","year":"2021","unstructured":"Akcay, A. et al. VI-RADS score and tumor contact length in MRI: a potential method for the detection of muscle invasion in bladder cancer. Clin. Imaging 77, 25\u201336 (2021).","journal-title":"Clin. Imaging"},{"key":"830_CR41","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1007\/s00330-021-07765-5","volume":"31","author":"MI Metwally","year":"2021","unstructured":"Metwally, M. I. et al. The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur. Radiol. 31, 6949\u20136961 (2021).","journal-title":"Eur. Radiol."},{"key":"830_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14584","volume":"75","author":"M Erkoc","year":"2021","unstructured":"Erkoc, M. et al. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer. Int. J. Clin. Pract. 75, e14584 (2021).","journal-title":"Int. J. Clin. Pract."},{"key":"830_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ajur.2021.06.001","volume":"9","author":"K Ghanshyam","year":"2022","unstructured":"Ghanshyam, K. et al. Validation of vesical imaging reporting and data system score for the diagnosis of muscle-invasive bladder cancer: a prospective cross-sectional study. Asian J. Urol. 9, 467\u2013472 (2022).","journal-title":"Asian J. Urol."},{"key":"830_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan, S., Cakir, I. M., Oguz, U., Bekci, T. & Demirelli, E. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion? Abdom. Radiol. 47, 771\u2013780 (2022).","journal-title":"Abdom. Radiol."},{"key":"830_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","volume":"127","author":"M Bicchetti","year":"2022","unstructured":"Bicchetti, M. et al. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study. Radiol. Med. 127, 881\u2013890 (2022).","journal-title":"Radiol. Med."},{"key":"830_CR46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.5152\/dir.2022.201108","volume":"28","author":"U O\u011fuz","year":"2022","unstructured":"O\u011fuz, U. et al. Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results. Diagn. Interv. Radiol. 28, 396\u2013402 (2022).","journal-title":"Diagn. Interv. Radiol."},{"key":"830_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.eururo.2021.02.021","volume":"80","author":"RT Bryan","year":"2021","unstructured":"Bryan, R. T. et al. Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study. Eur. Urol. 80, 12\u201315 (2021).","journal-title":"Eur. Urol."},{"key":"830_CR48","doi-asserted-by":"publisher","first-page":"110587","DOI":"10.1016\/j.ejrad.2022.110587","volume":"157","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer. Eur. J. Radiol. 157, 110587 (2022).","journal-title":"Eur. J. Radiol."},{"key":"830_CR49","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1007\/s00261-021-02963-7","volume":"46","author":"SA Ahmed","year":"2021","unstructured":"Ahmed, S. A., Taher, M. G. A., Ali, W. A. & Ebrahem, M. A. E. S. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer. Abdom. Radiol. 46, 2712\u20132721 (2021).","journal-title":"Abdom. Radiol."},{"key":"830_CR50","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/jmri.24663","volume":"41","author":"HT Nguyen","year":"2015","unstructured":"Nguyen, H. T. et al. Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters: chemotherapeutic response in bladder cancer. J. Magn. Reson. Imaging 41, 1374\u20131382 (2015).","journal-title":"J. Magn. Reson. Imaging"},{"key":"830_CR51","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2013.52.4785","volume":"32","author":"TK Choueiri","year":"2014","unstructured":"Choueiri, T. K. et al. Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. J Clin Oncol 32, 1889\u20131894 (2014).","journal-title":"J Clin Oncol"},{"key":"830_CR52","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ejrad.2013.08.008","volume":"82","author":"SB Donaldson","year":"2013","unstructured":"Donaldson, S. B. et al. Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect. Eur. J. Radiol. 82, 2161\u20132168 (2013).","journal-title":"Eur. J. Radiol."},{"key":"830_CR53","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.eururo.2006.01.022","volume":"49","author":"B Ph. Schrier","year":"2006","unstructured":"Ph. Schrier, B., Peters, M., Barentsz, J. O. & Witjes, J. A. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer. Eur. Urol. 49, 698\u2013703 (2006).","journal-title":"Eur. Urol."},{"key":"830_CR54","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.clon.2022.04.001","volume":"34","author":"S Hafeez","year":"2022","unstructured":"Hafeez, S. et al. Assessing bladder radiotherapy response with quantitative diffusion-weighted magnetic resonance imaging analysis. Clin. Oncol. 34, 630\u2013641 (2022).","journal-title":"Clin. Oncol."},{"key":"830_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.urology.2009.06.111","volume":"75","author":"S Yoshida","year":"2010","unstructured":"Yoshida, S. et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 75, 387\u2013391 (2010).","journal-title":"Urology"},{"key":"830_CR56","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1200\/JCO.2010.31.5721","volume":"29","author":"A Choudhury","year":"2011","unstructured":"Choudhury, A. et al. Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. J. Clin. Oncol. 29, 733\u2013738 (2011).","journal-title":"J. Clin. Oncol."},{"key":"830_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.euo.2020.06.004","volume":"4","author":"M Bandini","year":"2020","unstructured":"Bandini, M. et al. The value of multiparametric magnetic resonance imaging sequences to assist in the decision making of muscle-invasive bladder cancer. Eur. Urol. Oncol. 4, 829\u2013833 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"830_CR58","unstructured":"Proietti, S. Introducing the EAU Equality, Diversity, Inclusion Taskforce. uroweb https:\/\/uroweb.org\/news\/eau-launches-equality-diversity-inclusion-taskforce (2022)."},{"key":"830_CR59","doi-asserted-by":"publisher","first-page":"61.e1","DOI":"10.1016\/j.urolonc.2021.07.005","volume":"40","author":"R Kufukihara","year":"2022","unstructured":"Kufukihara, R. et al. Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: comparison with diagnostic cystoscopy. Urol. Oncol. 40, 61.e1\u201361.e8 (2022).","journal-title":"Urol. Oncol."},{"key":"830_CR60","unstructured":"University of Birmingham. UOB BladderPath: Image Directed Redesign of Bladder Cancer Treatment Pathway. University of Birmingham https:\/\/www.birmingham.ac.uk\/research\/crctu\/trials\/bladder-path\/index.aspx (2023)."},{"key":"830_CR61","doi-asserted-by":"publisher","unstructured":"Murali, S. et al. Bringing MRI to low\u2010 and middle\u2010income countries: directions, challenges and potential solutions. NMR Biomed. https:\/\/doi.org\/10.1002\/nbm.4992 (2023).","DOI":"10.1002\/nbm.4992"},{"key":"830_CR62","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1007\/s00330-022-08766-8","volume":"32","author":"MC da Silva","year":"2022","unstructured":"da Silva, M. C. et al. The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program. Eur. Radiol. 32, 7494\u20137503 (2022).","journal-title":"Eur. Radiol."},{"key":"830_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2021.04.034","volume":"80","author":"RT Bryan","year":"2021","unstructured":"Bryan, R. T. et al. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an imaging-guided pathway replace the current paradigm for muscle-invasive bladder cancer? Eur. Urol. 80, 18\u201319 (2021).","journal-title":"Eur. Urol."},{"key":"830_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/BLC-170110","volume":"3","author":"HT Nguyen","year":"2017","unstructured":"Nguyen, H. T. et al. Quantitative assessment of heterogeneity in bladder tumor MRI diffusivity: can response be predicted prior to neoadjuvant chemotherapy? Bladder Cancer 3, 237\u2013244 (2017).","journal-title":"Bladder Cancer"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00830-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00830-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T13:03:39Z","timestamp":1712581419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-023-00830-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1038\/s41585-023-00830-2","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"9 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}